Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
#Pharmacovigilance Outsourcing Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?#_x000D_
The pharmacovigilance outsourcing market has experienced substantial growth in recent years. It is anticipated to expand from $7.24 billion in 2025 to $8.51 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 17.6%. This historical increase can be ascribed to a rising number of new drug approvals, heightened pharmacovigilance awareness within pharmaceutical companies, a deficit of internal PV expertise, increased regulatory oversight, and the broadening scope of global clinical trials._x000D_
_x000D_
The pharmacovigilance outsourcing market is projected for significant expansion over the coming years, with its size anticipated to reach $16.09 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 17.2%. This projected growth during the forecast period is driven by several factors, including the integration of AI and data analytics into PV processes, increased reliance on outsourcing to CRO and BPO providers, the widespread adoption of cloud-based pharmacovigilance platforms, the broadening of global safety reporting requirements, and increased investment in IT infrastructure and technological support. Key trends observed during this period encompass a rising uptake of outsourced pharmacovigilance services by pharmaceutical companies, stricter regulatory compliance and reporting standards, increased automation in adverse drug reaction (ADR) capture and case processing, the development of knowledge management and data integration solutions, and a heightened emphasis on risk management and quality assurance services._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Pharmacovigilance Outsourcing Market Industry Drivers: What’s Behind The Revenue Growth?#_x000D_
The expansion in clinical trial volumes is anticipated to drive forward the pharmacovigilance outsourcing market. These trials represent research investigations designed to assess the safety, effectiveness, and potential adverse reactions of new therapies, medications, or medical instruments. The increase in clinical trials stems from various factors, such as a heightened emphasis on individualized medicine, a greater prevalence of chronic illnesses, supportive regulations, and the global spread of research activities. By employing specialized knowledge and capabilities, pharmacovigilance outsourcing in clinical trials improves drug safety surveillance, ensuring adherence to regulatory standards and boosting operational effectiveness. As an illustration, in December 2024, data from the Association of the British Pharmaceutical Industry (ABPI), a UK-based trade association, showed that the number of industry clinical trials started in the UK rose to 426 in 2023, up from 411 in 2022. Consequently, the growing frequency of clinical trials is propelling the expansion of the pharmacovigilance outsourcing market._x000D_
_x000D_
#Pharmacovigilance Outsourcing Market Segment Analysis And Revenue Potential#_x000D_
The pharmacovigilance outsourcing market covered in this report is segmented – _x000D_
_x000D_
1) By Type: Adverse Drug Reaction Capture (ADR), Case Processing, Reporting And Submission, Report Publishing, Quality Check, Risk Management, Knowledge Management, Enabling Architecture_x000D_
2) By Service Provider: Contract Research Organization, Business Processing Outsourcing_x000D_
3) By End User: Pharmaceutical Industry, Research Organization, Other End Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Adverse Drug Reaction Capture (ADR): Automated ADR Reporting Tools, Manual ADR Reporting Solutions, ADR Data Mining Software _x000D_
2) By Case Processing: Case Intake and Triage Services, Medical Review and Evaluation Services, Data Entry and Management Services _x000D_
3) By Reporting And Submission: Regulatory Reporting Services, Submission to Health Authorities, Compliance Tracking Services _x000D_
4) By Report Publishing: Clinical Study Report Publishing, Safety Update Report Publishing, Final Study Report Publishing _x000D_
5) By Quality Check: Quality Assurance Services, Audit and Inspection Services, Compliance Monitoring Services _x000D_
6) By Risk Management: Risk Assessment Services, Risk Minimization Strategies, Benefit-Risk Evaluation Services _x000D_
7) By Knowledge Management: Data Management Solutions, Pharmacovigilance Database Management, Knowledge Sharing Platforms _x000D_
8) By Enabling Architecture: IT Infrastructure Solutions, Data Integration Services, Technology Platform Support _x000D_
_x000D_
#Pharmacovigilance Outsourcing Market Growth Trends: What’s Shaping The Future Outlook?_x000D_
Leading companies active in the pharmacovigilance outsourcing market are prioritizing the development of innovative solutions, such as cloud-based data lake platforms, to streamline pharmacovigilance case processing and safety data management procedures, thereby enhancing clinical research registries and ensuring adherence to regulatory mandates. A cloud-based data lake platform functions as a centralized repository capable of storing and managing vast quantities of raw data in its original format until it is required. For example, in December 2023, Thermo Fisher Scientific Inc., a US-based biotechnology and laboratory equipment company, introduced CorEvidence, specifically designed to augment clinical research registries. This platform aims to simplify pharmacovigilance case processing by integrating multiple data sources and optimizing the coding, classification, and reporting of adverse events. Its significance lies in offering scalable, compliant, and auditable safety management, which improves CorEvitas clinical research registries and supports long-term post-authorization safety studies across a variety of therapeutic areas._x000D_
_x000D_
#Pharmacovigilance Outsourcing Market Key Players Shaping Industry Direction#_x000D_
Major companies operating in the pharmacovigilance outsourcing market are ACCENTURE PLC, International Business Machines Corporation (IBM), Tata Consultancy Services, Capgemini SE, Cognizant Technology Solutions Corporation, IQVIA Holdings Inc., Wipro Limited, ICON PLC, Syneos Health, Genpact limited, Parexel International Corp, Veeva Systems Inc., Medpace Holdings Inc., ProPharma Group, Pharmalex GmbH, PrimeVigilance Ltd., Veristat LLC, United BioSource LLC, Lambda Therapeutic Research, ArisGlobal, Biomapas _x000D_
_x000D_
#View The Full Pharmacovigilance Outsourcing Market Report:#_x000D_
_x000D_
#Pharmacovigilance Outsourcing Market Geographic Spread And Regional Opportunities#_x000D_
North America was the largest region in the pharmacovigilance outsourcing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacovigilance outsourcing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model